Effects of self-acupressure on quality of life and abdominal pain severity among patients with inflammatory bowel disease: A randomized sham-controlled trial

Abstract

Background

Acupressure is being used by patients to relieve functional gastrointestinal disorders.

Objective

The impact of acupressure on quality of life (QoL) and pain has been shown in patients with both acute and chronic conditions. However, its effects on individuals with inflammatory bowel disease (IBD) remain uncertain. This trial aims to explore the potential effects of self-acupressure on QoL and abdominal pain severity in IBD patients.

Methods

This randomized sham-controlled trial involved 56 outpatients with IBD referred to the emergency department, who were randomly assigned to either an acupressure group or a sham group. All patients received standard care along with daily follow-up calls. Those in the acupressure group applied pressure at four specific points, while the sham group engaged in superficial self-touch at corresponding points. Both interventions occurred three times daily for four weeks. The quality of life was assessed using the IBDQ-9 questionnaire and a visual analog scale (VAS) at both baseline and endpoint.

Results

The mean IBDQ-9 score was significantly higher in the acupressure group compared to the sham group at the trial's end (P < 0.001). Likewise, the mean VAS score was notably lower in the acupressure group at the endpoint (P < 0.001). Additionally, the change in mean IBDQ-9 scores from baseline to endpoint favored the acupressure group significantly (P < 0.001), and the same significant difference was observed for the mean VAS score change (P < 0.001).

Conclusion

Daily follow-up-guided self-acupressure may improve quality of life and alleviate abdominal pain in IBD sufferers.